L3VLUP
ProSign in

WVE in the 13F filings

Wave Life Sciences LTD · CUSIP Y95308105

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
14 Feb 2025
latest of these filings; the earliest 12 Feb 2025
Managers listing it
4
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 4 listed it in both
Shares listed
10,689,065
combined, among listed positions
Reported value
$132m
combined, at the quarter end

Among the 94 comparable managers: 0 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,845,705.

Managers listing WVE in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

4 of 4 holders

ActionFiling
Maverick Capital Ltd8,261,242$102m1.84%Trimmed-1,786,27814 Feb 2025 (the filing on sec.gov)
Artisan Partners LP1,906,790$24munder 0.1%Trimmed-53,68012 Feb 2025 (the filing on sec.gov)
Woodline Partners LP451,813$5.6munder 0.1%Held014 Feb 2025 (the filing on sec.gov)
PDT Partners LLC69,220$856k0.08%Trimmed-5,74714 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

No increase among listed positions.

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

0246201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
WVE by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20171$14mn.a.n.a.
Q4 20171$3.0mn.a.n.a.
Q1 20182$3.4mn.a.n.a.
Q2 20183$16mn.a.n.a.
Q3 20184$98mn.a.n.a.
Q4 20183$90mn.a.n.a.
Q1 20195$141mn.a.n.a.
Q2 20193$90mn.a.n.a.
Q3 20192$85mn.a.n.a.
Q4 20191$447kn.a.n.a.
Q1 20201$1.1mn.a.n.a.
Q2 20201$623kn.a.n.a.
Q3 20203$2.3mn.a.n.a.
Q4 20202$2.3mn.a.n.a.
Q1 20211$17mn.a.n.a.
Q2 20211$21mn.a.n.a.
Q3 20211$16mn.a.n.a.
Q4 20211$18mn.a.n.a.
Q1 20221$11mn.a.n.a.
Q2 20221$25mn.a.n.a.
Q3 20223$30mn.a.n.a.
Q4 20223$59mn.a.n.a.
Q1 20232$31mn.a.n.a.
Q2 20231$24mn.a.n.a.
Q3 20232$45mn.a.n.a.
Q4 20232$50m20
Q1 20242$53m02
Q2 20242$39m11
Q3 20244$103m31
Q4 20244$132m03
Q1 20252$86m20
Q2 20252$68m01
Q3 20252$70m11
Q4 20251$158m1710
Q1 20261$74m205
Q2 20261$60m1611

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

WVE and LLY →WVE and JNJ →WVE and VRTX →Choose a stock to compare with WVE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own WVE, latest filings →Back to the 13F Explorer →